Plant-based diet proven to reduce Alzheimer's risk

In a pilot study conducted by scientists at Rush University Medical Centre in Chicago, it was found that diet rich in green leafy vegetables, beans, berries, whole grains and wine can help to slow normal brain ageing and cognitive decline

id-100343258

Alzheimer's disease is the sixth leading cause of death in the US

A recent study has found that plant based Mediterranean-Dash Diet Intervention for Neurodegenerative Delay (Mind) substantially slows down cognitive decline and ageing can prevent or delay the onset of Alzheimer's and other neurodegenerative disorders.

In a pilot study conducted by scientists at Rush University Medical Centre in Chicago, it was found that diet rich in green leafy vegetables, beans, berries, whole grains and wine can help to slow normal brain ageing and cognitive decline.

Mind is a hybrid of the Mediterranean diet rich in olive oil and vegetables and the DASH eating plan designed to control high blood pressure. The diet consists of 15 dietary components and recommends at least three servings of whole grains, a salad and another vegetable each day and a glass of wine. Beans and poultry should be eaten at least twice a week and fish once a week.

The researchers tested the cognitive ability of 960 adults with an average age of 81.4 years at 40 retirement community and senior public housing units in the Chicago area over a period of 4.7 years. They uncovered a slower decline in mental ability among the elderly who adhered most closely to the diet.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

MTaI Welcomes PMO's Intervention on the Forthcoming National Medical Device

Sunday, 23 Apr 2017   |   Medical Technology Association of India (MTaI)

Business Wire IndiaWe welcome the PMO’s intervention on the National Medical Device Policy (NMDP) .

Replicor discloses achievement of 1 year functional control of HBV and

Friday, 21 Apr 2017   |   Replicor Inc.

Business Wire India Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic

AWARE Gleneagles Global Hospitals Announces the Launch of Neuro Stroke

Friday, 21 Apr 2017   |   Gleneagles Global Hospitals, a Parkway Pantai Enterprise

Business Wire IndiaAWARE Gleneagles Global Hospitals, a Parkway Pantai Enterprise today announced the

BusinessWire India.com - Pharmaceutical

Bwi-logo

Replicor discloses achievement of 1 year functional control of HBV and

Friday, 21 Apr 2017   |   Replicor Inc.

Business Wire India Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic

AWARE Gleneagles Global Hospitals Announces the Launch of Neuro Stroke

Friday, 21 Apr 2017   |   Gleneagles Global Hospitals, a Parkway Pantai Enterprise

Business Wire IndiaAWARE Gleneagles Global Hospitals, a Parkway Pantai Enterprise today announced the

BusinessWire India.com - Medical Devices

Bwi-logo

MTaI Welcomes PMO's Intervention on the Forthcoming National Medical Device

Sunday, 23 Apr 2017   |   Medical Technology Association of India (MTaI)

Business Wire IndiaWe welcome the PMO’s intervention on the National Medical Device Policy (NMDP) .

AWARE Gleneagles Global Hospitals Announces the Launch of Neuro Stroke

Friday, 21 Apr 2017   |   Gleneagles Global Hospitals, a Parkway Pantai Enterprise

Business Wire IndiaAWARE Gleneagles Global Hospitals, a Parkway Pantai Enterprise today announced the

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email

X